Search results
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoModerna confirmed it's in discussions with the U.S. government to move forward with its bird flu...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 3 days agoModerna (MRNA 3.70%) jumped into the limelight when it started developing a coronavirus vaccine...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 12 hours agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 3 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 7 days agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...